gynecologic oncology
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Stages ? b1~? A2 cervical cancer, ?~? uterine malignant tumors, and various stages of ovarian malignant tumors undergoing satisfactory ovarian tumor cell reduction surgery with clear pathological diagnosis (FIGO 2009 staging); (2) Age 18-75 years old; (3) Willing to undergo surgery without any contraindications; (4) All patient surgeries include pelvic lymph node dissection; (5) Enrolled patients must understand and voluntarily participate in the study, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Previous history of major lower limb trauma or surgery; (2) Prior to surgery, there was a history of lower limb thrombosis or primary lower limb lymphedema; (3) Lower extremity edema caused by cardiogenic or nephrogenic diseases before surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence of Lower limb lymphedema; | — |
Secondary
| Measure | Time frame |
|---|---|
| the metastasis rate of circumflex iliac nodes; | — |
Countries
China
Contacts
Affiliated Cancer Hospital of Guangxi Medical University